November 13, 2018 PR-M11-18-NI-042
MARLBOROUGH, Mass. /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City.
David Pierce, executive vice president and president, MedSurg and Susie Lisa, vice president, Investor Relations, will participate in a 60-minute roundtable discussion session with the host analyst beginning at approximately 9:30 a.m. EST. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.
A replay of the webcast will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investorsbeginning approximately one hour following the completion of the event.
CONTACTS
Media:
Investors:
Kate Haranis
Susie Lisa, CFA
508-683-6585 (office)
508-683-5565 (office)
Media Relations
Investor Relations
Boston Scientific Corporation
Boston Scientific Corporation
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.